UIRF Open Office Hour

Open office hours will be held on the first and third Monday of each month from 2:00-3:00 PM in Callen Conference Room (Room 5), Gilmore Hall. No appointment is needed.

UIRF

The University of Iowa Research Foundation (UIRF) - a 501C3 corporation - commercializes University of Iowa developed technologies and inventions through licensing and new venture formation, and manages the subsequent revenue stream.

The UIRF’s primary functions are:

  • New Ventures - identifying and developing new high growth UI technology spinout companies suitable for venture capital financing
  • Licensing - finding suitable partners for commercializing UI technologies and inventions
  • Intellectual property services - which include protecting UI inventions through patents and copyrights, advising on intellectual property terms for Clinical Trials and Sponsored Research, and executing out-going material transfers

Our Mission

The UIRF’s mission is to:

  • Champion the commercialization of selected UI inventions for public benefit and for return on investment
  • Catalyze economic development and an entrepreneurial culture in Iowa
  • Build the vitality and sustainability of the University and the community through technology commercialization
  • Serve the research mission for continued innovation

Our Vision

The UIRF aspires to maximize public benefit through commercial use of UI technologies, excellence in commercialization, and long term sustainability.

Available Technologies

Click here to search our available technologies

Annual Reports

Click here to view UIRF annual reports

Newly Issued Patents

US 8,630,721 (January 14, 2014)
Hybrid Cochlear Implant

US 8,621,701 (January 7, 2014)
Dental Brush Assembly and Method for Making the Same

US 8,618,352 (December 31, 2013)
Transgenic Porcine Models of Cystic Fibrosis

US 8,616,702 (December 31, 2013)
Hybrid Laser Ophthalmoscope

US 8,577,822 (November 5, 2013)
Data-driven Approach to Modeling Sensors wherein Optimal Time Delays are Determined for a First Set of Predictors and Stored as a Second Set of Predictors

US 8,571,278 (October 29, 2013)
System and Methods for Multi-object Multi-surface Segmentation

US 8,524,881 (September 3, 2013)
Reduction of Off-target RNA Interference Toxicity

US 8,524,879 (September 3, 2013)
RNA Interference Suppresion of Neurodegenerative Diseases and Methods of Use Thereof

US 8,503,057 (September 3, 2013)
Systems and Methods for Microwave Tomography

US 8,503,057 (August 6, 2013)
Electrically-tunable Optical Devices

US 8,487,088 (July 16, 2013)
RNA Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof

US 8,481,710 (July 9, 2013)
RNA Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof

US 8,440,656 (May 14, 2013)
Methods of Treating Pulmonary Diseases and Disorders by Modulating Calcium/Calmodulin Dependent Protein Kinase II Activity

US 8,358,819 (January 22, 2013)
System and Methods for Image Segmentation in N-dimensional Space

US 8,343,911 (January 1, 2013)
Methods of Inhibiting and Treating Bacterial Biofilms by Metal Chelators

More recently issued patents

6 Gilmore Hall, 112 N. Capitol Street, Iowa City, IA 52242     phone: 319-335-4546 fax: 319-335-4486 © University of Iowa 2007. All rights reserved.